Julie Eastland is President and Chief Executive Officer of Zentalis Pharmaceuticals, Inc. (ZNTL). The company reported total compensation of $1,300,731 for fiscal year 2025.
| Salary | $700,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $99,772 |
| Option awards | $56,975 |
| Non-equity incentive plan | $441,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $2,984 |
| Total | $1,300,731 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Zentalis Pharmaceuticals, Inc. filed April 30, 2026, accession 0001725160-26-000027.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $700,000 | $0 | $99,772 | $56,975 | $441,000 | $0 | $2,984 | $1,300,731 |
| FY2024 | President and Chief Executive Officer | $94,231 | $250,000 | — | $7,791,824 | $52,471 | — | $383 | $8,188,909 |
Totals as disclosed in each year's own compensation disclosure for Zentalis Pharmaceuticals, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Andrea Paul | Former Chief Legal Officer and Corporate Secretary | $2,988,669 |
| Julie Eastland this page | President and Chief Executive Officer | $1,300,731 |
| Mark Lackner | Former Chief Scientific Officer | $1,229,349 |
| Ingmar Bruns | Chief Medical Officer | $869,843 |
| James Bucher | Chief Legal Officer and Corporate Secretary | $659,973 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Zentalis Pharmaceuticals, Inc. compensation brief.
Julie Eastland's compensation sits inside Zentalis Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Zentalis Pharmaceuticals, Inc. (ZNTL) compensation brief